Previous 10 | Next 10 |
Progyny (PGNY): Q3 GAAP EPS of $0.05 beats by $0.01.Revenue of $98.9M (+61.6% Y/Y) beats by $6.36M.Q4 guidance: Revenue of $95.4M-$100.4M, reflecting growth of 47% to 54% vs consensus of $99.5M ; Net income of $5.1M-$6.6 M, income/share of $0.05-$0.07; Adjusted EBITDA of $9.0M-$10.3M.FY2...
Reports Record Third Quarter Revenue of $98.9 Million Raises Revenue Guidance to $340.0 to $345.0 Million for Full Year 2020, Reflecting Growth of 48% to 50% Affirms Preliminary View of a Minimum of $525 Million in 2021 Revenue NEW YORK, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Progyny, In...
[[AAXN]], [[ACLS]], [[ADT]], [[AGO]], [[AIG]], [[AINV]], [[ALRM]], [[ALTR]], [[AMCR]], [[AMH]], [[AMN]], [[ANGI]], [[APPN]], [[ATGE]], [[ATRC]], [[AVLR]], [[AYX]], [[AZPN]], [[BFAM]], [[BGS]], [[BHF]], [[BIGC]], [[BILL]], [[BKNG]], [[BLDP]], [[BMRN]], [[BNFT]], [[CABO]], [[CARG]], [[CDAY]], [...
Progyny (NASDAQ:PGNY) is scheduled to announce Q3 earnings results on Thursday, November 5th, after market close.The consensus EPS Estimate is $0.06 (+100.0% Y/Y) and the consensus Revenue Estimate is $92.54M (+51.2% Y/Y).Over the last 1 year, PGNY has beaten EPS estimates 75% of the time and...
NEW YORK, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, and RMA of New York, a Manhattan-based fertility clinic, presented original research at the ...
NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, will partic...
Fertility health is a fast-growing space within the emerging "femtech" industry -- the area of technology that focuses on women's health. According to a report by Market Research Future, the fertility services market is expected to grow at an 8.5% rate through 2023 to reach $36 billion in total ...
Progyny (NASDAQ: PGNY ) announces that Mark Livingston, executive VP of finance, has been promoted to CFO, effective September 15, 2020. More news on: Progyny, Inc., Read more ...
NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that Mark Livingston, Progyny’s Executive Vice President of Finance,...
Progyny, Inc. (PGNY) Q2 2020 Earnings Conference Call August 5, 2020 04:45 PM ET Company Participants James Hart - Vice President, Investor Relations David Schlanger - Chief Executive Officer Pete Anevski - President, Chief Financial Officer and Chief Operating Officer Confere...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period ended June 30, 2024 after the close of the market on Tuesday, August 6, 20...
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that it will host its inaugural Investor Day in New York City on Monday, August 12, 2024, from 9:00 A.M. Eastern Time...
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced an expansion of its global offering with the acquisition of Apryl, a Berlin-based fertility benefits platform founded...